Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-09-21-Speech-2-498"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2010-09-21"^^xsd:date2
dcterms:Is Part Of	lp_eu:Pharmacovigilance of medicinal products (amendment of Regulation (EC) No 726/2004) - Pharmacovigilance (amendment of Directive 2001/83/EC) (debate)2
dcterms:Language	"pl"^^xsd:language2
lpv:document identification number	"en.20100921.18.2-498"2
lpv:hasSubsequent	lp_eu:2010-09-21-Speech-2-4992
lpv:speaker	lp:Elżbieta Katarzyna Łukacijewska2
lpv:spokenAs	substitute; Delegation for relations with the People's Republic of China (2009-09-16--2014-06-30)3 member; Delegation to the Euronest Parliamentary Assembly (2009-09-16--2014-06-30)3 member; REGI (2009-09-14--2012-01-18)3 member; Delegation to the EU-Ukraine Parliamentary Cooperation Committee (2009-09-16--2014-06-30)3 substitute; ENVI (2009-07-16--2012-01-18)3 member; EPP (2009-07-14--2014-06-30)3 unknown; Platforma Obywatelska (2009-07-14--2014-06-30)3
lpv:translated text	"I would like to begin by congratulating Mrs McAvan and everyone who worked on the directive and the regulation on pharmacovigilance. The issues dealt with in these documents are very important for the health system but, above all, they are important for the safety of patients. Statistics show that nearly 200 000 people die every year from the side effects of medicines they have taken, around 50% of patients do not take medicines in accordance with medical recommendations and over 70% of patients would like to be able to obtain reliable information on medicines and procedures on the Internet. Therefore, it is evident that, together with the change to the principles for registering pharmaceutical products, it has become essential to introduce a system which – using the Internet – will supply reliable information about medicines. However, without correct reporting of all side effects of medicines by medical personnel, patients and drug companies, there will not be good monitoring of the safety of pharmacotherapy. For it is first necessary to notice certain signals which are indicative of potential problems and to take action on this basis. This is a new step towards complete openness and transparency of information in the field of pharmacology. An important element of pharmacovigilance is the posting of information about medicines on the Internet in all the official languages of the European Union in a form which will enable its content to be understood by all patients. However, attention should be drawn to the fact that the Internet, besides being a very good source of information, may also contain false information. Therefore, it is essential to conduct continuous monitoring and updating of the system, because it is paramount that the system be effective. Also important are the proposals concerning increasing the transparency of the Union system of monitoring by using public hearings for gathering information on side effects. This is a useful tool for carrying out monitoring, especially if the whole of society and not just a small group of specialists is going to be able to participate in it, and it will certainly increase patient confidence in medicines."@en1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph